BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: da Silva Maia PI, Deflon VM, Abram U. Gold(III) complexes in medicinal chemistry. Future Medicinal Chemistry 2014;6:1515-36. [DOI: 10.4155/fmc.14.87] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Maia PI, Carneiro ZA, Lopes CD, Oliveira CG, Silva JS, de Albuquerque S, Hagenbach A, Gust R, Deflon VM, Abram U. Organometallic gold(iii) complexes with hybrid SNS-donating thiosemicarbazone ligands: cytotoxicity and anti-Trypanosoma cruzi activity. Dalton Trans 2017;46:2559-71. [PMID: 28154849 DOI: 10.1039/c6dt04307k] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 5.3] [Reference Citation Analysis]
2 Silva RTC, Dalmolin LF, Moreto JA, Oliveira CG, Machado AEH, Lopez RFV, Maia PIS. Development of gold(III) thiosemicarbazonate complex–loaded PLGA nanoparticles: characterization and sustained release studies. J Nanopart Res 2020;22. [DOI: 10.1007/s11051-020-05064-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Gonçalves AC, Carneiro ZA, Oliveira CG, Danuello A, Guerra W, Oliveira RJ, Ferreira FB, Veloso-silva LL, Batista FA, Borges JC, de Albuquerque S, Deflon VM, Maia PI. Pt II , Pd II and Au III complexes with a thiosemicarbazone derived from diacethylmonooxime: Structural analysis, trypanocidal activity, cytotoxicity and first insight into the antiparasitic mechanism of action. European Journal of Medicinal Chemistry 2017;141:615-31. [DOI: 10.1016/j.ejmech.2017.10.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
4 Casado-sánchez A, Martín-santos C, Padrón JM, Mas-ballesté R, Navarro-ranninger C, Alemán J, Cabrera S. Effect of electronic and steric properties of 8-substituted quinolines in gold(III) complexes: Synthesis, electrochemistry, stability, interactions and antiproliferative studies. Journal of Inorganic Biochemistry 2017;174:111-8. [DOI: 10.1016/j.jinorgbio.2017.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
5 Feng Y, Li D, Wang Q, Wang S, Meng X, Shao Z, Zhu M, Wang X. A carbazole-based mitochondria-targeted two-photon fluorescent probe for gold ions and its application in living cell imaging. Sensors and Actuators B: Chemical 2016;225:572-8. [DOI: 10.1016/j.snb.2015.11.081] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
6 Ostrovskaya LA, Grehova AK, Korman DB, Osipov AN, Bluhterova NV, Fomina MM, Rikova VA, Abzaeva KA. Cellular effects of the antitumor drug aurumacryl. BIOPHYSICS 2017;62:485-9. [DOI: 10.1134/s0006350917030150] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
7 Salsi F, Bulhões Portapilla G, Simon S, Roca Jungfer M, Hagenbach A, de Albuquerque S, Abram U. Effect of Fluorination on the Structure and Anti- Trypanosoma cruzy Activity of Oxorhenium(V) Complexes with S , N , S -Tridentate Thiosemicarbazones and Benzoylthioureas. Synthesis and Structures of Technetium(V) Analogues. Inorg Chem 2019;58:10129-38. [DOI: 10.1021/acs.inorgchem.9b01260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
8 Porchia M, Pellei M, Marinelli M, Tisato F, Del Bello F, Santini C. New insights in Au-NHCs complexes as anticancer agents. Eur J Med Chem 2018;146:709-46. [PMID: 29407992 DOI: 10.1016/j.ejmech.2018.01.065] [Cited by in Crossref: 77] [Cited by in F6Publishing: 57] [Article Influence: 19.3] [Reference Citation Analysis]
9 Espinosa AV, Costa DDS, Tunes LG, Monte‐neto RLD, Grazul RM, Almeida MV, Silva H. Anticancer and antileishmanial in vitro activity of gold(I) complexes with 1,3,4‐oxadiazole‐2( 3H )‐thione ligands derived from δ‐D‐gluconolactone. Chem Biol Drug Des 2021;97:41-50. [DOI: 10.1111/cbdd.13757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
10 Khan E, Khan S, Gul Z, Muhammad M. Medicinal Importance, Coordination Chemistry with Selected Metals (Cu, Ag, Au) and Chemosensing of Thiourea Derivatives. A Review. Critical Reviews in Analytical Chemistry. [DOI: 10.1080/10408347.2020.1777523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Dandash F, Leger DY, Diab-Assaf M, Sol V, Liagre B. Porphyrin/Chlorin Derivatives as Promising Molecules for Therapy of Colorectal Cancer. Molecules 2021;26:7268. [PMID: 34885849 DOI: 10.3390/molecules26237268] [Reference Citation Analysis]
12 Galassi R, Luciani L, Gambini V, Vincenzetti S, Lupidi G, Amici A, Marchini C, Wang J, Pucciarelli S. Multi-Targeted Anticancer Activity of Imidazolate Phosphane Gold(I) Compounds by Inhibition of DHFR and TrxR in Breast Cancer Cells. Front Chem 2020;8:602845. [PMID: 33490036 DOI: 10.3389/fchem.2020.602845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kyhoiesh HAK, Al-adilee KJ. Synthesis, spectral characterization and biological activities of Ag(I), Pt(IV) and Au(III) complexes with novel azo dye ligand (N, N, O) derived from 2-amino-6-methoxy benzothiazole. Chem Pap . [DOI: 10.1007/s11696-022-02072-9] [Reference Citation Analysis]
14 Barolli JP, Maia PI, Colina-vegas L, Moreira J, Plutin AM, Mocelo R, Deflon VM, Cominetti MR, Camargo-mathias MI, Batista AA. Heteroleptic tris-chelate ruthenium(II) complexes of N,N-disubstituted-N′-acylthioureas: Synthesis, structural studies, cytotoxic activity and confocal microscopy studies. Polyhedron 2017;126:33-41. [DOI: 10.1016/j.poly.2017.01.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
15 Lima JC, Nascimento RD, Vilarinho LM, Borges AP, Silva LH, Souza JR, Dinelli LR, Deflon VM, da Hora Machado AE, Bogado AL, Maia PI. Group 10 metal complexes with a tetradentate thiosemicarbazonate ligand: Synthesis, crystal structures and computational insights into the catalysis for C–C coupling via Mizoroki-Heck reaction. Journal of Molecular Structure 2020;1199:126997. [DOI: 10.1016/j.molstruc.2019.126997] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Ratia C, Cepas V, Soengas R, Navarro Y, Velasco-de Andrés M, Iglesias MJ, Lozano F, López-Ortiz F, Soto SM. A CS-Cyclometallated Gold(III) Complex as a Novel Antibacterial Candidate Against Drug-Resistant Bacteria. Front Microbiol 2022;13:815622. [PMID: 35308343 DOI: 10.3389/fmicb.2022.815622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mazzei L, Massai L, Cianci M, Messori L, Ciurli S. Medicinal Au(I) compounds targeting urease as prospective antimicrobial agents: unveiling the structural basis for enzyme inhibition. Dalton Trans 2021;50:14444-52. [PMID: 34585201 DOI: 10.1039/d1dt02488d] [Reference Citation Analysis]
18 Stankovic AS, Kasalovic MP, Bukonjic AM, Mijajlovic MZ, Tomovic DL, Nikolic MV. Biological Activity of Au(III) Complexes. Serbian Journal of Experimental and Clinical Research 2019;0:000010247820190050. [DOI: 10.2478/sjecr-2019-0050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
19 Rettondin AR, Carneiro ZA, Gonçalves AC, Ferreira VF, Oliveira CG, Lima AN, Oliveira RJ, de Albuquerque S, Deflon VM, Maia PI. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs. Eur J Med Chem 2016;120:217-26. [PMID: 27191616 DOI: 10.1016/j.ejmech.2016.05.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
20 Massai L, Messori L, Micale N, Schirmeister T, Maes L, Fregona D, Cinellu MA, Gabbiani C. Gold compounds as cysteine protease inhibitors: perspectives for pharmaceutical application as antiparasitic agents. Biometals 2017;30:313-20. [DOI: 10.1007/s10534-017-0007-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
21 Silva MJSA, Gois PMP, Gasser G. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications. Chembiochem 2021;22:1740-2. [PMID: 33507625 DOI: 10.1002/cbic.202100015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ceramella J, Mariconda A, Iacopetta D, Saturnino C, Barbarossa A, Caruso A, Rosano C, Sinicropi MS, Longo P. From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerases. Bioorg Med Chem Lett 2020;30:126905. [PMID: 31874823 DOI: 10.1016/j.bmcl.2019.126905] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
23 Ghosh S, Khan MA, Bhattacharyya A, Alam MA, Zangrando E, Guchhait N. Cu( ii )-induced twisting of the biphenyl core: exploring the effect of structure and coordination environment of biphenyl-based chiral copper( ii ) complexes on interaction with calf-thymus DNA. New J Chem 2020;44:20275-84. [DOI: 10.1039/c9nj06184c] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Pradhan AK, Shyam A, Mondal P. Quantum Chemical Investigations on the Hydrolysis of Gold(III)-Based Anticancer Drugs and Their Interaction with Amino Acid Residues. ACS Omega 2021;6:28084-97. [PMID: 34723008 DOI: 10.1021/acsomega.1c04168] [Reference Citation Analysis]
25 Milaeva E, Shpakovsky D, Dyadchenko V, Gryzlov A, Gracheva Y, Antonenko T, Parulava M, Albov D, Aslanov L, Dubova L, Shevtsov P, Neganova M, Shevtsova E. Synthesis and biological activity of novel Au(I) complexes with a protective antioxidant 2,6-di-tert-butylphenol group. Polyhedron 2017;127:512-9. [DOI: 10.1016/j.poly.2016.08.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
26 Martín-Santos C, Michelucci E, Marzo T, Messori L, Szumlas P, Bednarski PJ, Mas-Ballesté R, Navarro-Ranninger C, Cabrera S, Alemán J. Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies. J Inorg Biochem 2015;153:339-45. [PMID: 26490713 DOI: 10.1016/j.jinorgbio.2015.09.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
27 Borges AP, Gaspari APS, Oliveira CG, de Sousa SF, da Silva RS, Deflon VM, Machado AEH, Patrocínio AOT, Maia PIS. Photophysical and DFT Studies of Cationic Ag(I) Complexes with Thiosemicarbazides Derived from p -Toluenesulfohydrazide. ChemistrySelect 2018;3:2108-14. [DOI: 10.1002/slct.201800079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Ndagi U, Mhlongo N, Soliman ME. Metal complexes in cancer therapy - an update from drug design perspective. Drug Des Devel Ther 2017;11:599-616. [PMID: 28424538 DOI: 10.2147/DDDT.S119488] [Cited by in Crossref: 352] [Cited by in F6Publishing: 85] [Article Influence: 70.4] [Reference Citation Analysis]
29 Haque A, Al-balushi RA, Khan MS. σ-Acetylide complexes for biomedical applications: Features, challenges and future directions. Journal of Organometallic Chemistry 2019;897:95-106. [DOI: 10.1016/j.jorganchem.2019.06.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
30 Borges AP, Carneiro ZA, Prado FS, Souza JR, Furlan e Silva LH, Oliveira CG, Deflon VM, de Albuquerque S, Leite NB, Machado AE, Patrocinio AO, Maia PI. Cu(I) complexes with thiosemicarbazides derived from p-toluenesulfohydrazide: Structural, luminescence and biological studies. Polyhedron 2018;155:170-9. [DOI: 10.1016/j.poly.2018.08.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yeo CI, Ooi KK, Tiekink ERT. Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy? Molecules 2018;23:E1410. [PMID: 29891764 DOI: 10.3390/molecules23061410] [Cited by in Crossref: 65] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
32 Yang Z, Jiang G, Xu Z, Zhao S, Liu W. Advances in alkynyl gold complexes for use as potential anticancer agents. Coordination Chemistry Reviews 2020;423:213492. [DOI: 10.1016/j.ccr.2020.213492] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
33 Possato B, Dalmolin LF, Pereira LM, Alves JQ, Silva RTC, Gelamo RV, Yatsuda AP, Lopez RFV, de Albuquerque S, Leite NB, Maia PIDS. Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: Cytotoxicity and interactions with biomolecular targets. Eur J Pharm Sci 2021;162:105834. [PMID: 33826936 DOI: 10.1016/j.ejps.2021.105834] [Reference Citation Analysis]
34 Marzo T, Ferraro G, Merlino A, Messori L. Protein Metalation by Inorganic Anticancer Drugs. In: Scott RA, editor. Encyclopedia of Inorganic and Bioinorganic Chemistry. Wiley; 2011. pp. 1-17. [DOI: 10.1002/9781119951438.eibc2747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Tunes LG, Morato RE, Garcia A, Schmitz V, Steindel M, Corrêa-Junior JD, Dos Santos HF, Frézard F, de Almeida MV, Silva H, Moretti NS, de Barros ALB, do Monte-Neto RL. Preclinical Gold Complexes as Oral Drug Candidates to Treat Leishmaniasis Are Potent Trypanothione Reductase Inhibitors. ACS Infect Dis 2020;6:1121-39. [PMID: 32283915 DOI: 10.1021/acsinfecdis.9b00505] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
36 Ostrovskaya LA, Korman DB, Grehova AK, Osipov AN, Bluhterova NV, Fomina MM, Rikova VA, Abzaeva KA. Experimental study of the antitumor effect of aurumacryl. Russ Chem Bull 2017;66:2333-8. [DOI: 10.1007/s11172-017-2025-z] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Salsi F, Bulhões Portapilla G, Schutjajew K, Roca Jungfer M, Goulart A, Hagenbach A, de Albuquerque S, Abram U. Organometallic Gold(III) Complexes with Tridentate Halogen‐Substituted Thiosemicarbazones: Effects of Halogenation on Cytotoxicity and Anti‐Parasitic Activity. Eur J Inorg Chem 2019;2019:4455-62. [DOI: 10.1002/ejic.201900904] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
38 Patanjali P, Kumar R, Sourabh, Kumar A, Chaudhary P, Singh R. Reviewing Gold(III) complexes as effective biological operators. MGC 2018;17:35-52. [DOI: 10.3233/mgc-180247] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Adokoh CK. Therapeutic potential of dithiocarbamate supported gold compounds. RSC Adv 2020;10:2975-88. [DOI: 10.1039/c9ra09682e] [Cited by in Crossref: 11] [Article Influence: 5.5] [Reference Citation Analysis]
40 Fontinha D, Sousa SA, Morais TS, Prudêncio M, Leitão JH, Le Gal Y, Lorcy D, Silva RAL, Velho MFG, Belo D, Almeida M, Guerreiro JF, Pinheiro T, Marques F. Gold(iii) bis(dithiolene) complexes: from molecular conductors to prospective anticancer, antimicrobial and antiplasmodial agents. Metallomics 2020;12:974-87. [PMID: 32391537 DOI: 10.1039/d0mt00064g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
41 De Nisi A, Bergamini C, Leonzio M, Sartor G, Fato R, Naldi M, Monari M, Calonghi N, Bandini M. Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold( i ) complexes. Dalton Trans 2016;45:1546-53. [DOI: 10.1039/c5dt02905h] [Cited by in Crossref: 23] [Cited by in F6Publishing: 1] [Article Influence: 3.8] [Reference Citation Analysis]
42 Chaves JDS, Tunes LG, de J. Franco CH, Francisco TM, Corrêa CC, Murta SM, Monte-neto RL, Silva H, Fontes APS, de Almeida MV. Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents. European Journal of Medicinal Chemistry 2017;127:727-39. [DOI: 10.1016/j.ejmech.2016.10.052] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
43 Lopes CD, Possato B, Gaspari APS, Oliveira RJ, Abram U, Almeida JPA, Rocho FDR, Leitão A, Montanari CA, Maia PIS, da Silva JS, de Albuquerque S, Carneiro ZA. Organometallic Gold(III) Complex [Au(Hdamp)(L14)]+ (L1 = SNS-Donating Thiosemicarbazone) as a Candidate to New Formulations against Chagas Disease. ACS Infect Dis 2019;5:1698-707. [PMID: 31419384 DOI: 10.1021/acsinfecdis.8b00284] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
44 Vedenyapina MD, Kulaishin SA, Kuznetsov VV, Makhova NN, Kazakova MM. Kinetics and mechanism of gold anode corrosion in a weakly basic aqueous solution of hexamethylenetetramine (urotropine). Russ Chem Bull 2022;71:52-8. [DOI: 10.1007/s11172-022-3375-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Bestgen S, Seidl C, Wiesner T, Zimmer A, Falk M, Köberle B, Austeri M, Paradies J, Bräse S, Schepers U, Roesky PW. Double-Strand DNA Breaks Induced by Paracyclophane Gold(I) Complexes. Chem Eur J 2017;23:6315-22. [DOI: 10.1002/chem.201605237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
46 Altaf M, Monim-Ul-Mehboob M, Kawde AN, Corona G, Larcher R, Ogasawara M, Casagrande N, Celegato M, Borghese C, Siddik ZH, Aldinucci D, Isab AA. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status. Oncotarget 2017;8:490-505. [PMID: 27888799 DOI: 10.18632/oncotarget.13448] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
47 Aliaga-Lavrijsen M, Herrera RP, Villacampa MD, Gimeno MC. Efficient Gold(I) Acyclic Diaminocarbenes for the Synthesis of Propargylamines and Indolizines. ACS Omega 2018;3:9805-13. [PMID: 31459109 DOI: 10.1021/acsomega.8b01352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]